High Katherine A

Director at CRISPR Therapeutics AG · on record since Jun 9, 2026
Director at INCYTE CORP · on record since Jun 10, 2026
Director at Spark Therapeutics, Inc. · on record since Jan 29, 2015
See Remarks at Spark Therapeutics, Inc. · on record since Jan 29, 2015

Insider trading activity of High Katherine A

Transactions on record: 122; since Feb 6, 2015

Open-market buys: 1; $16.1K

Open-market sells: 35; $12.8M

Companies traded: 3; last filing Jun 10, 2026

Figures computed from official regulatory filings — .

Companies where High Katherine A has traded

INCYTE CORP16 tx · Jun 10, 2026
CRISPR Therapeutics AG8 tx · Jun 9, 2026
Spark Therapeutics, Inc.98 tx · $66.4M · Dec 17, 2019

Track record of High Katherine A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of High Katherine A

Co-insiders of High Katherine A

CAGNONI PABLO JCRISPR Therapeutics AG +1
14159 capital (GP), LLCINCYTE CORP
14159, L.P.INCYTE CORP
667, L.P.INCYTE CORP
Altschuler StevenSpark Therapeutics, Inc.
Andrews Patricia SINCYTE CORP
ARIKO BARRY AINCYTE CORP
Baker Biotech Capital (GP), LLCINCYTE CORP
Baker Biotech Capital II (GP), LLCINCYTE CORP
Baker Biotech Capital III (GP), LLCINCYTE CORP
Baker Bros. Advisors (GP) LLCINCYTE CORP
BAKER BROS. ADVISORS LPINCYTE CORP
Baker Bros. Capital (GP), LLCINCYTE CORP
Baker Brothers Life Sciences LPINCYTE CORP
BAKER FELIXINCYTE CORP
BAKER JULIANINCYTE CORP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Value · USD	Src
INCYTE CORP	Jun 10, 2026	Award	1,642	—	SEC
INCYTE CORP	Jun 10, 2026	AwardD (derivative)	6,111	—	SEC
CRISPR Therapeutics AG	Jun 9, 2026	AwardD (derivative)	13,000	—	SEC
INCYTE CORP	Jun 12, 2025	AwardD (derivative)	9,216	—	SEC
INCYTE CORP	Jun 12, 2025	Award	2,518	—	SEC
CRISPR Therapeutics AG	Jun 6, 2025	AwardD (derivative)	13,000	—	SEC
INCYTE CORP	Jun 14, 2024	AwardD (derivative)	12,517	—	SEC
INCYTE CORP	Jun 14, 2024	Award	2,830	—	SEC
CRISPR Therapeutics AG	May 31, 2024	AwardD (derivative)	13,000	—	SEC
INCYTE CORP	Jun 16, 2023	Award	2,505	—	SEC
INCYTE CORP	Jun 16, 2023	AwardD (derivative)	11,294	—	SEC
CRISPR Therapeutics AG	Jun 9, 2023	AwardD (derivative)	13,000	—	SEC
INCYTE CORP	Jun 17, 2022	AwardD (derivative)	9,124	—	SEC
INCYTE CORP	Jun 17, 2022	Award	2,144	—	SEC
CRISPR Therapeutics AG	Jun 10, 2022	AwardD (derivative)	12,000	—	SEC
CRISPR Therapeutics AG	Jun 14, 2021	AwardD (derivative)	10,000	—	SEC
INCYTE CORP	May 28, 2021	AwardD (derivative)	8,010	—	SEC
INCYTE CORP	May 28, 2021	Award	1,923	—	SEC
CRISPR Therapeutics AG	Jun 15, 2020	AwardD (derivative)	15,000	—	SEC
INCYTE CORP	May 28, 2020	Award	1,282	—	SEC
INCYTE CORP	May 28, 2020	AwardD (derivative)	10,514	—	SEC
INCYTE CORP	Mar 30, 2020	Award	139	—	SEC
INCYTE CORP	Mar 30, 2020	AwardD (derivative)	1,285	—	SEC
Spark Therapeutics, Inc.	Dec 17, 2019	OtherD (derivative)	-23,625	—	SEC
Spark Therapeutics, Inc.	Dec 17, 2019	OtherD (derivative)	-15,750	—	SEC

Company	Filed	Type	Qty	Value · USD	Src
INCYTE CORP	Jun 10, 2026	Award	1,642	—	SEC
INCYTE CORP	Jun 10, 2026	AwardD (derivative)	6,111	—	SEC
CRISPR Therapeutics AG	Jun 9, 2026	AwardD (derivative)	13,000	—	SEC
INCYTE CORP	Jun 12, 2025	AwardD (derivative)	9,216	—	SEC
INCYTE CORP	Jun 12, 2025	Award	2,518	—	SEC
CRISPR Therapeutics AG	Jun 6, 2025	AwardD (derivative)	13,000	—	SEC
INCYTE CORP	Jun 14, 2024	AwardD (derivative)	12,517	—	SEC
INCYTE CORP	Jun 14, 2024	Award	2,830	—	SEC
CRISPR Therapeutics AG	May 31, 2024	AwardD (derivative)	13,000	—	SEC
INCYTE CORP	Jun 16, 2023	Award	2,505	—	SEC
INCYTE CORP	Jun 16, 2023	AwardD (derivative)	11,294	—	SEC
CRISPR Therapeutics AG	Jun 9, 2023	AwardD (derivative)	13,000	—	SEC
INCYTE CORP	Jun 17, 2022	AwardD (derivative)	9,124	—	SEC
INCYTE CORP	Jun 17, 2022	Award	2,144	—	SEC
CRISPR Therapeutics AG	Jun 10, 2022	AwardD (derivative)	12,000	—	SEC
CRISPR Therapeutics AG	Jun 14, 2021	AwardD (derivative)	10,000	—	SEC
INCYTE CORP	May 28, 2021	AwardD (derivative)	8,010	—	SEC
INCYTE CORP	May 28, 2021	Award	1,923	—	SEC
CRISPR Therapeutics AG	Jun 15, 2020	AwardD (derivative)	15,000	—	SEC
INCYTE CORP	May 28, 2020	Award	1,282	—	SEC
INCYTE CORP	May 28, 2020	AwardD (derivative)	10,514	—	SEC
INCYTE CORP	Mar 30, 2020	Award	139	—	SEC
INCYTE CORP	Mar 30, 2020	AwardD (derivative)	1,285	—	SEC
Spark Therapeutics, Inc.	Dec 17, 2019	OtherD (derivative)	-23,625	—	SEC
Spark Therapeutics, Inc.	Dec 17, 2019	OtherD (derivative)	-15,750	—	SEC